Using immunohistochemistry, EZH2 protein was detected in 44% of 110 [22], 78% of 165 [17], 84% of 119 [27], 89% of 520 [16], 100% of 257 [28], 100% of 185 [19], and 100% of 50 [29] kidney cancers. Here, EZH2 is linked to kidney cancer.